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 Study Design.  Retrospective analysis of data from patients 
participating in the Lumbar Spinal Stenosis Outcome Study (LSOS). 
 Objective.  The aim of LSOS was to assess clinical outcomes after 
surgical or nonoperative treatment in patients with and without prior 
epidural steroid injections. 
 Summary of Background Data.  Epidural steroid injections 
(ESI), a common treatment modality, reduce symptoms in the short-
term, but according to a subgroup analysis from the Spine Patient 
Outcomes Research Trial (SPORT) they reduce the amount of 
improvement after subsequent surgical or nonoperative treatment. 
 Methods.  The data of 281 patients with lumbar spinal stenosis 
who had completed baseline and 6-month follow-up assessments 
were analyzed. Patients completed the Spinal Stenosis Measure 
(SSM). Changes in the SSM scores from baseline to follow-up were 
compared between patients with and without prior ESI, for the 
surgical and nonsurgical treatment groups. 
 Results.  The mean (SD) age of the patients was 75 (8.7) years. 
229 patients underwent surgery and 111 of these had received 
an ESI in the 12 months before surgery. Of the 52 patients treated 
nonoperatively, 29 had received a prior ESI. The unadjusted changes 
(improvement) in the SSM-symptom scores between baseline and 6 
months’ follow up were: surgery and prior ESI 0.95, surgery and no 
prior ESI 0.78 ( P  = 0.15); no surgery and prior ESI 0.28, no surgery 
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 Patients with lumbar spinal stenosis and neurogenic clau-dication can be offered 3 different treatment modalities with increasing invasiveness: nonoperative treatment 
with physical exercise and/or analgesics, epidural injections 
of steroids and/or analgesics, and surgical decompression 
with or without fusion. 1 Although the effi cacy of epidural ste-
roid injections (ESIs) in patients with lumbar stenosis is still 
a matter of debate, the number of injections in such patients 
tripled in the Medicare population from 1994 to 2001. 2 Some 
trial results indicate a short-term benefi t of ESIs in patients 
with lumbar spinal stenosis, 3–7 but the majority of the stud-
ies evaluating the longer-term effi cacy (6 mo to 2 yr) show 
no clinically relevant improvement compared with physical 
therapy 1 and the Guideline of the “North American Spine 
Society” recommends ESIs with some reluctance in patients 
with lumbar stenosis. 8 , 9 
 Done in the correct manner, under contrast-enhanced fl uo-
roscopy, or CT-guided, ESIs are considered safe. The com-
plication rate, including infection and bleeding, is very low. 
However, a recent study evaluating clinical outcome after 
ESIs reported disquieting results: those patients treated with 
ESIs were less likely to benefi t from subsequent surgical or 
nonoperative treatment compared with patients who had 
not received ESIs. 10 In both groups of patients, treated sur-
gically or nonoperatively, pain and physical function were 
worse in the subsequent 4-year follow-up period in patients 
and no prior ESI 0.29 ( P  = 0.85). When adjusted for confounding 
factors, the reduction in SSM-symptom score was greater for surgery 
than for nonoperative treatment by 0.41 points ( P  < 0.001); the 
effect of having had an ESI prior to study entry was –0.08 ( P  = 0.40). 
 Conclusion.  The analysis of outcomes in the LSOS cohort 
provided no evidence that ESIs have a negative effect on the short-
term outcome of surgery or nonoperative treatment in patients with 
lumbar spinal stenosis. 
 Key words:  lumbar spinal stenosis ,  epidural steroid injection , 
 surgical treatment ,  nonoperative treatment ,  Spinal Stenosis Measure . 
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who had undergone ESIs in the 3 months prior to treatment. 
This result was unexpected, and the study was criticized for 
various reasons, 11 , 12 including the failure to use a condition-
specifi c instrument such as the Spinal Stenosis Measure (SSM) 
as the primary outcome measure. Further studies were recom-
mended in order to establish whether the fi ndings could be 
reproduced. 
 The aim of this study is to report the clinical outcome after 
surgical or nonoperative treatment in patients participating 
in the Lumbar Spinal Stenosis Outcome Study (LSOS) 13 who 
either did or did not receive an ESI within the 12 months prior 
to enrollment. 
 PATIENTS AND METHODS 
 The LSOS working group was established in Switzerland 
in 2009, to perform a multicenter observational study 
evaluating the treatment and prognosis of patients with 
lumbar spinal stenosis. 13 This substudy is part of the LSOS. 
The study was approved by the local ethical committee 
and conducted in accordance with the Declaration of 
Helsinki. 14 All patients received written and oral infor-
mation about the study and gave their written informed 
consent to participate. 
 Eligibility Criteria and Patients 
 The inclusion criteria were: (1) aged 50 years or more; 
(2) uni- or bilateral neurogenic claudication (defi ned by 
pain in the buttocks and/or lower extremities provoked 
by walking or extended standing and relieved by rest and/
or bending forward; (3) verifi ed diagnosis of spinal steno-
sis by Magnetic Resonance Imaging (MRI) or Computer 
tomography (CT); (4) expected life expectancy of more 
than 1 year; (5) able to give informed consent; (6) available 
for follow-up and able to complete questionnaires in the 
German language. The exclusion criteria were: (1) cauda 
equina syndrome requiring urgent surgery; (2) current 
fracture, infection, or signifi cant deformity ( > 15 ° lumbar 
scoliosis); (3) current enrolment in another spine related 
treatment study; (4) clinically relevant peripheral arterial 
disease (confi rmed by vascular specialist in patients with-
out palpable pulses in the lower limb). 
 For the assessment of a potentially harmful effect of 
ESIs— i.e., less improvement after surgical or nonoperative 
treatment—all patients in the LSOS cohort with a 6-month 
follow-up were identifi ed. These patients were included and 
allocated to 1 of 4 groups: (1) Patients who had undergone 
surgery (decompression, with or without fusion) between 
baseline and 6 months’ follow-up, and with ESI in the 12 
months before surgery; (2) Patients who had undergone 
surgery between baseline and 6 months’ follow-up, without 
any prior ESI; (3) Patients treated nonoperatively (physical 
therapy and/or oral analgesics, but no epidural injections) 
between baseline and 6 months’ follow-up, with ESI in the 
12 months before inclusion in the study; (4) Patients treated 
nonoperatively (physical therapy and/or oral analgesics) 
between baseline and 6 months’ follow-up, without any 
prior ESI. 
 Data Collection 
 Demographic data, and information about the duration of 
symptoms and epidural injections in the past were collected 
at baseline. At baseline and 6 months’ follow-up, the follow-
ing patient-oriented questionnaires (German language ver-
sions) were used to gather information about the patients’ 
complaints: 
1.  the SSM, a disease specifi c questionnaire 15 , 16 with 3 sub-
scales assessing the severity of symptoms (SSM symptom 
severity scale), physical function (SSM physical func-
tion), and satisfaction with treatment results (SSM sat-
isfaction). The SSM symptom severity scale comprises a 
pain subdomain and a neuroischemic subdomain. Each 
item is rated on a Likert scale. Response options on the 
SSM symptom severity scale range from “no symptoms” 
[1] to “very severe symptoms” [5]; on the SSM function 
scale, from “yes, comfortably” [1] to “no, could not per-
form” [5], and on the SSM satisfaction scale, from “very 
satisfi ed” [1] to “very dissatisfi ed” [4]; 
2.  the Roland Morris Disability Questionnaire, assessing 
back pain related functional disability [score 0 (no dis-
ability) to 24 (severe disability)]  17 ; 
3.  pain intensity scale (numeric rating scale NRS), quantify-
ing the intensity of leg pain within the last 7 days [score 
0 (no pain) to 10 (extreme pain)] 18 ; 
4.  EuroQol-5D (EQ-5D) for the measurement of quality of 
life (sum score 0–100; higher values indicate higher qual-
ity of life). 19 , 20 
5.  The Hospital Anxiety and Depression Score (HADS) at 
baseline only (sum score for anxiety 0–21, and sum score 
for depression 0–21; 21 indicates severe anxiety or severe 
depression) 21 
6.  Chronic Illness Rating Scale for the measurement of co-
morbidities (sum score 0–56; higher values indicate a 
higher number of and/or more severe comorbidities) 22 
 In addition, detailed information was recorded about treat-
ments received between baseline and 6 months’ follow-up. 
 Imaging Procedures 
 MRI of the lumbar spine was carried out at baseline, if not 
already done in the 3 months prior to inclusion in the study. 
In patients with contraindications to MRI, computer tomog-
raphy was performed. Board-certifi ed, experienced radiolo-
gists evaluated images from all patients and confi rmed the 
presence of radiological lumbar spinal stenosis. 
 Data Analysis 
 All data were collected on paper forms and were entered inde-
pendently by 2 persons into a Filemaker database (FileMaker 
Inc.) and checked for inconsistencies. Descriptive statistics are 
presented as means and standard deviations for continuous 
variables and as numbers and percentages of total for cat-
egorical variables. The primary analyses comprised compari-
sons of the change in the SSM score and its subscale scores 
from baseline to 6 months’ follow-up between those with and 
without previous epidural steroid injections, for each of the 
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2 treatment groups (surgical and nonsurgical treatment). In 
addition, changes in the SSM scores between baseline and 
6 months’ follow-up were compared between patients with 1 
or more than 1 previous epidural steroid injections, for each 
of the 2 treatment groups. The Wilcoxon rank sum test was 
used to evaluate raw differences between the groups. 
 Additionally, multiple linear regression models were fi tted 
separately to the 4 SSM subscales Function, Symptoms, Pain 
Domain, and Neuroischemic Pain at 6 months. The indepen-
dent variables were surgical treatment (yes/no) and epidural 
steroid injection prior to baseline (yes/no). Additionally, the 
respective SSM subscale baseline score, age, gender, HADS 
score anxiety, HADS score depression, pain duration more 
than 6 months, and the CIRS comorbidity score were included 
in the regression model to adjust for potential confounding. 
We also included an interaction term between surgical treat-
ment and ESI, to determine whether any effect of ESI might 
differ between the treatment groups. If the  P -value for the 
interaction effect was 0.05 or more, the interaction term was 
removed from the model.  P -values less than 0.05 were consid-
ered statistically signifi cant. All analyses were conducted with 
R for Windows (R Core Team (2014). R: A language and envi-
ronment for statistical computing. R Foundation for Statistical 
Computing, Vienna, Austria. URL  http://www.R-project.org/ .) 
 RESULTS 
 By  June 1, 2014, 415 patients were enrolled in the study. 
Data at baseline and 6 months’ follow-up were available for 
369 patients in the LSOS ( Figure 1 ). Of these, 88 had received 
1 or more ESIs between baseline and 6 months’ follow up 
and were excluded from further analyses. For 46 patients, no 
data were available for the 6-month follow-up. The remain-
ing 281 were included in the present study. A total of 229 
patients had undergone surgery between baseline and 
6 months’ follow-up: 111 of these had received an ESI in 
the 12 months prior to surgery and 118 had not. 52 patients 
were treated nonoperatively: 29 had received an ESI in the 12 
months before study entry and 23 had not. The exact number 
of ESIs received by the patients in the previous 12 months are 
shown in  Table 1 . 
 The patients’ demographic details and other baseline data 
are shown in  Table 2 . The mean age of the patients was 75 
(SD 8.7) years. In the nonoperative treatment arm, 60% were 
female, and in the surgical group, 50%. In about (2/3) of 
the patients, symptoms of lumbar spinal stenosis had been 
present for more than 1 year and in about 10%, less than 3 
months. More than 80% of the patients were retired. 
 The surgical interventions comprised posterior lumbar 
decompression (with the specifi c technique being dependent 
on the surgeon's preference and including bilateral (hemi)
laminotomy through a unilateral approach, interlaminar lam-
inotomy, or laminectomy), with or without additional fusion, 
depending on the surgeon's assessment of the individual 
pathology ( Table 3 ). In the group with prior ESI, 3 patients 
were reoperated between baseline and 6 months’ follow-up; 
in the group with no prior ESI, 4 patients were reoperated. 
 Mean baseline scores for all subdomains of the SSM were 
higher in patients undergoing surgery compared with patients 
in the nonoperative treatment group ( Table 4 ). The same was 
true for leg pain and Roland Morris disability scores ( Table 5 ). 
Copyright © 2015 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
369 pts., data available at baseline (T0) and 
6 months follow up (T6)
52 pts.,conservative treatment 
between T0 and T6
229 pts., surgical treatment between T0 
and T6
88 pts. received ESI between T0 
and T6, excluded
patients received ESI
 between T0 and T6
29 pts. ESI before T0 23 pts. no ESI  before T0 111 pts. ESI before T0 118 pts. no ESI before T0
415 pts. enrolled  in cohort study (T0)
46 pts. no complete follow-up data 
set at T6
 Figure 1.  Patient fl ow: number of eligible patients (pts.) at baseline with and without prior (antecedent yr) epidural steroid injections (ESI) under-
going surgical or nonoperative treatment. 
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Quality of life at baseline, quantifi ed by the EQ-5D question-
naire, was lower in the group undergoing surgery ( Table 5 ). 
 At 6 months’ follow-up, improvements in unadjusted SSM 
scores, Roland Morris and EQ-5D were more pronounced 
in the surgical group compared with the nonoperative group 
( Tables 4 and 5 ). 
 Changes in the unadjusted SSM scores between baseline 
and 6 months’ follow-up were not statistically signifi cantly 
different between patients with and without prior ESI, in 
either the surgical or nonoperative patient groups ( Table 4 ). 
Similarly, changes in the unadjusted SSM scores between 
patients with 1 previous ESI and patients with more than 1 
ESI were not statistically signifi cantly different ( Table 6 ). 
 Adjusted mean change scores from baseline in SSM Symp-
toms, SSM Function, SSM Pain Domain, and SSM Neu-
roischemic Pain in relation to the treatment modality (sur-
gery yes/no, epidural steroid injection yes/no) are displayed 
in  Figure 2 . The adjusted effect of surgery ( vs. nonoperative 
treatment; negative values indicate greater improvement 
with surgery) was  − 0.41 ( P  < 0.001) for SSM Symptoms, 
 − 0.03 ( P  = 0.81) for SSM Function,  − 0.48 ( P  = 0.002) for 
SSM Pain, and  − 0.34 ( P  = 0.002) for SSM Neuroischemic 
Pain. The adjusted effect of ESI prior to study entry (versus 
no prior ESI; negative values indicate greater improvement 
with ESI) was  − 0.08 ( P  = 0.40) for SSM Symptoms, 0.37 
( P  = 0.02) for SSM Function, 0.0003 ( P  = 0.99) for SSM 
Pain, and  − 0.10 ( P  = 0.24) for SSM Neuroischemic Pain. 
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 TABLE 1.  Number of Epidural Steroid Injections 
Before Baseline/Before Surgery for 
Patients With Conservative Treatment 
and Surgical Treatment 
Number of Steroid 
Injections
Conservative 
Treatment 
(Number of Patients)
Surgery 
(Number of 
Patients)
1 20 54
2 5 27
3 2 11
4 1 10
5 0 4
>5 1 5
29 111
 TABLE 2.  Baseline Data of the Patients in the Four Specifi ed Groups: Demographics, Comorbidities, 
and Duration of Symptoms (ESI) 
Nonoperative Treatment Surgical Treatment
ESI (n  = 29) No-ESI (n  = 23) ESI (n  = 111) No-ESI (n  = 118)
Age, mean (SD), yr 76.2  ± 10.1 74.1  ± 8.3 74.2  ± 9.2 75.4  ± 8.0
Female no. (%) 17 (59%) 14 (61%) 55 (50%) 59 (50%)
Educational level no. (%)
 Compulsory education 6 (21%) 6 (26%) 21 (19%) 26 (22%)
 Baccalaureate/apprenticeship 22 (76%) 16 (70%) 76 (68%) 78 (66%)
 University degree 1 (3%) 1 (4%) 14 (13%) 14 (12%)
Employment status no. (%)
 Employed full or part time 5 (17%) 3 (13%) 23 (21%) 16 (14%)
 Retired 24 (83%) 20 (87%) 88 (79%) 102 (86%)
Comorbidities no. (%)
 Osteoarthritis of the hip 4 (14%) 2 (9%) 15 (14%) 17 (14%)
 Gonarthrosis 8 (28%) 3 (10%) 16 (14%) 17 (14%)
 Peripheral neuropathy 3 (10%) 1 (3%) 8 (7%) 11 (9%)
 Obstructive lung disease 3 (10%) 2 (9%) 5 (5%) 6 (5%)
 Heart failure 3 (10%) 1 (3%) 3 (3%) 7 (6%)
 Coronary heart disease 2 (7%) 0 6 (6%) 8 (7%)
 M. Parkinson 1 (3%) 0 1 (1%) 2 (2%)
Duration of symptoms no. (%)
  < 3 months 4 (14%) 3 (10%) 10 (9%) 14 (12%)
 3–6 months 2 (7%) 2 (9%) 16 (14%) 17 (14%)
 6–12 months 2 (7%) 4 (17%) 19 (17%) 13 (11%)
  > 12 months 21 (72%) 14 (61%) 65 (59%) 72 (61%)
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There was just 1 signifi cant interaction between surgery and 
ESI prior to study entry, for SSM Function: the interaction 
effect was  − 0.46 ( P  = 0.01) (having had an ESI led to less 
improvement in the nonoperative group but not the surgical 
group). 
 The change-scores for the NRS, Roland Morris, and 
EQ-5D followed the same pattern as the SSM, with 2 excep-
tions: compared with no prior ESI, nonoperative patients who 
had received a prior ESI showed a reduced quality of life (EQ-
5D) and a slight increase of NRS values between baseline and 
6 months’ follow-up, indicating a worsening of the symptom 
state ( Table 5 ). 
 DISCUSSION 
 The results of our study indicate that ESIs administered to 
patients with lumbar spinal stenosis in the year prior to surgery 
have no relevant impact on the outcome of surgical treatment, 
as measured by the disease-specifi c SSM. The changes in SSM 
scores between baseline and 6 months’ follow-up were not sig-
nifi cantly different between patients with and without prior 
ESI. At baseline, the SSM scores were higher (indicating more 
severe symptoms) in the patients undergoing surgery compared 
with patients treated by nonoperative measures. Improvement 
after 6 months was more pronounced in the surgically treated 
group. Similar fi ndings were observed for the other outcome 
Copyright © 2015 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
 TABLE 3.  Surgical Procedures Performed and Number of Decompressed Levels in Patients With (ESI) 
and Without (No ESI) Prior Epidural Injections 
Surgical Procedure, n (%) ESI (n  = 118) No-ESI (n  = 111)
Decompression only 94 (80%) 85 (77%)
Decompression and noninstrumented fusion 0 1 (1%)
Decompression and instrumented fusion 24 (20%) 25 (22%)
Multilevel fusion, n (%) 12 (10%) 15 (14%)
Levels decompressed, n (%)
 1 41 (35%) 41 (37%)
 2 44 (37%) 50 (45%)
 3 29 (25%) 17 (15%)
 4 4 (3%) 3 (3%)
 TABLE 4.  Differences in the Swiss SSM Scores (Mean  ± SD) Between Baseline (T 0 ) and 6 Months’ 
Follow-up (T 6 ) in Patients With Lumbar Spinal Stenosis Treated Surgically or Nonoperatively, 
With and Without Prior ESI 
Nonoperative 
Treatment
ESI (n  = 29) No ESI (n  = 23)
 P *T 0 T 6 Improvement T 0 T 6 Improvement
SSM-symptom 2.9  ± 0.7 2.6  ± 0.7 0.3 2.9  ± 0.9 2.6  ± 1.0 0.3 0.847
SSM-function 2.4  ± 0.9 2.1  ± 0.8 0.3 2.3  ± 0.9 1.8  ± 0.7 0.5 0.241
SSM-pain 3.6  ± 0.8 3.2  ± 0.9 0.4 3.5  ± 1.1 2.9  ± 1.1 0.6 0.589
SSM-neuroischemic 2.4  ± 0.9 2.2  ± 0.8 0.2 2.4  ± 1.0 2.4  ± 1.2 0.0 0.584
SSM-satisfaction 2.0  ± 0.7 2.0  ± 0.8
 Surgical Treatment 
 ESI (n  = 111)  No ESI (n  = 118) 
 T 0  T 6  T 0  T 6 
SSM-symptom 3.2  ± 0.5 2.3  ± 0.8 0.9 3.1  ± 0.6 2.3  ± 0.8 0.8 0.148
SSM-function 2.3  ± 0.7 1.6  ± 0.6 0.7 2.3  ± 0.7 1.7  ± 0.6 0.6 0.450
SSM-pain 3.8  ± 0.7 2.5  ± 1.0 1.3 3.7  ± 0.7 2.6  ± 1.1 1.1 0.517
SSM-neuroischemic 2.8  ± 0.7 2.1  ± 0.8 0.7 2.6  ± 0.8 2.1  ± 0.9 0.5 0.179
SSM-satisfaction 1.7  ± 0.6 1.8  ± 0.7
 *  P -values of comparison between the changes in patients with ESI and without ESI, Wilcoxon rank sum test. 
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measures—quality of life, leg pain, and disability, except that 
patients in the nonoperative treatment group with prior ESIs 
showed a worsening of quality of life and leg pain between 
baseline and 6 months’ follow up. An explanation for the dif-
ferences in leg pain and quality of life could be the higher pro-
portion of patients with the 2 comorbidities (gonarthritis 28% 
 vs. 10% and heart failure 10%  vs. 3%) in the group of patients 
with prior ESIs, compared with those without. 
 Radcliff  et al 10 reported that ESIs were associated with 
signifi cantly less improvement during 4 years’ follow-up in 
patients treated either surgically or nonoperatively for lum-
bar spinal stenosis. In several studies, detrimental compli-
cations after epidural steroid injections have been reported, 
such as infections, bleeding and spinal cord injuries, although 
the incidence is very low. 23 , 24 Until the results of the Spine 
Patient Outcomes Research Trial (SPORT) were published, 10 
Copyright © 2015 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
 TABLE 5.  Differences in the Numeric Rating Scale, Roland Morris Disability Questionnaire, and 
EQ-5D (Mean  ± SD) Between Baseline (T 0 ) and 6 Months’ Follow-up (T 6 ) in Patients With 
Lumbar Spinal Stenosis Treated Surgically or Nonoperatively, With and Without Prior 
Epidural Steroid Injections (ESI) 
Nonoperative 
Treatment
ESI (n  = 29) No ESI (n  = 23)
 P *T 0 T 6 Improvement T 0 T 6 Improvement
NRS 4.9  ± 2.4 5.4  ± 2.8 –0.5 5.1  ± 3.0 4.4  ± 2.9 0.7 0.316
Roland Morris 10.6  ± 6.2 8.9  ± 5.7 1.7 10.1  ± 6.7 8.8  ± 5.9 1.3 0.283
EQ-5D 72.8  ± 21.7 70.0  ± 20.0 – 2.8 68.7  ± 20.1 77.0  ± 15.2 8.3 0.047
 Surgical Treatment 
 ESI (n  = 111)  No ESI (n  = 118) 
 T 0  T 6  T 0  T 6 
NRS 6.8  ± 1.8 3.7  ± 4.6 3.1 6.3  ± 2.1 3.2  ± 2.6 3.1 0.656
Roland Morris 12.7  ± 4.9 8.2  ± 5.9 4.5 12.2  ± 5.1 8.1  ± 5.4 4.2 0.592
EQ-5D 65.4  ± 15.5 81.2  ± 15.0 15.8 66.6  ± 14.5 80.6  ± 16.8 14.0 0.337
 * P -values of comparison between the changes in patients with ESI and without ESI, Wilcoxon rank sum test. 
 TABLE 6.  Differences in the Swiss SSM Scores (Mean  ± SD) between Baseline (T 0 ) and 6 Months of 
Follow-up (T 6 ) in Patients With Lumbar Spinal Stenosis Treated Surgically or Conservative, 
With 1 and More Than 1 Prior ESI 
Conservative 
Treatment
1 ESI (n  = 20) More Than 1 ESI (n  = 9)
T 0 T 6 
Improve-
ment T 0 T 6 
Improve-
ment  P 
SSM-symptom 2.9  ± 0.8 2.5  ± 0.6 0.4 3.0  ± 0.7 3.0  ± 0.9 0.0 0.4222
SSM-function 2.4  ± 0.9 2.1  ± 0.8 0.3 2.4  ± 0.8 2.1  ± 0.8 0.3 0.887
SSM-pain 3.6  ± 0.8 3.0  ± 0.9 0.6 3.7  ± 0.8 3.5  ± 0.8 0.2 0.379
SSM-neuroischemic 2.3  ± 0.9 2.1  ± 0.7 0.2 2.6  ± 0.9 2.6  ± 0.9 0.0 0.722
SSM-satisfaction 2.0  ± 0.6 2.1  ± 0.8
 Surgical Treatment 
 1 Single ESI (n  = 54)  More Than 1 ESI (n  = 47) 
 T 0  T 6  T 0  T 6 
SSM-symptom 3.2  ± 0.5 2.2  ± 0.8 1.0 3.2  ± 0.6 2.3  ± 0.8 0.9 0.335
SSM-function 2.2  ± 0.7 1.5  ± 0.5 0.7 2.3  ± 0.7 1.6  ± 0.6 0.7 0.735
SSM-pain 3.8  ± 0.6 2.4  ± 1.1 1.4 3.8  ± 0.7 2.7  ± 0.9 1.1 0.157
SSM-neuroischemic 2.8  ± 0.6 2.0  ± 0.8 0.8 2.7  ± 0.8 2.1  ± 0.8 0.6 0.622
SSM-satisfaction 1.7  ± 0.7 1.8  ± 0.6
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 ➢ Key Points 
   ESIs are frequently used in the treatment of 
patients with lumbar spinal stenosis. 
   A recent publication from the SPORT reported 
that ESIs had a negative impact on the subse-
quent outcome of surgery and nonoperative 
treatment. 
   The results of the present study did not sup-
port those of SPORT and instead suggested no 
infl uence of prior ESIs on the outcome of surgi-
cal or nonoperative treatment for lumbar spinal 
stenosis. 
no negative consequences of ESIs in relation to subsequent 
treatment outcome had been suspected. 
 Our results do not support the fi ndings of the subgroup 
analysis in the SPORT, although the patient populations of 
the 2 studies were slightly different. The SPORT also included 
patients with radicular pain, 10 whereas our study included 
only patients with neurogenic claudication. Furthermore, we 
did not exclude patients with any form of spondylolisthesis 
per se. We only excluded patients with signifi cant (>15 ° ) sco-
liosis. Concerns regarding the validity of the conclusions of 
the SPORT trial, based on objections to some of the method-
ology, have been raised since its publication. 11 , 12 
 The number of patients treated with epidural steroid injec-
tions has increased enormously in the last 2 decades, although 
there is ongoing discussion concerning their effi cacy. The 
authors of a recently published randomized trial concluded 
that the combination of steroids and lidicocaine, compared 
with lidocaine only, offered a minimal benefi t after 3 weeks, 
but not after 6 weeks. 7 In the United States, more than 10 
million injections per annum are administered, not only—but 
to a large extent—in patients with lumbar stenosis. 25 Some 
insurance companies in the United States reimburse costs for 
surgery, only when a trial of treatment with epidural steroids 
has failed. 26 
 Our study has some limitations. The patients were not 
assigned randomly, either to surgical or nonoperative treat-
ment, or to ESIs or not. The LSOS is an observational study 
and the specifi c treatment to be administered was at the dis-
cretion of the physicians and their patients. This explains the 
differences in the SSM scores at baseline between surgical and 
nonoperative patients, with higher SSM scores in the surgi-
cally treated group. In both treatment groups (operative and 
nonoperative) there were no signifi cant differences between 
the 2 subgroups—ESI versus no ESI—for the adjusted SSM 
change scores from baseline to 6 months’ follow-up, except 
for SSM function in the nonoperative group. Patients in the 
ESI subgroups were similar with respect to age, sex, dura-
tion of symptoms, and SSM scores; however, we concede that 
other potentially relevant prognostic indicators could have 
been unevenly distributed between the groups, masking real 
differences in outcome. A second limitation of our study was 
the shorter follow-up of just 6 months compared with 4 years 
in the SPORT. However, Radcliff  et al 10 reported the differ-
ences in outcome at regular time-points during 4-year period, 
and according to the fi gure in their publication, the negative 
effect of ESIs on improvement in both the surgical and nonop-
erative groups was already noticeable after 6 months. A third 
limitation of the present study is the small number of patients 
in the nonoperative treatment group, limiting the precision of 
the results and potentially leading to a type II error (failure to 
reject a false null hypothesis). 
 The results of our study do not support the conclusion 
of the subanalysis of the SPORT. The analysis of outcomes 
after 6 months in the LSOS cohort provides no evidence that 
ESIs have a negative effect on the short-term outcome after 
surgery or nonoperative treatment in patients with lumbar 
spinal stenosis. 
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 Figure 2.  Adjusted mean changes ( ± SD) from baseline at 6 months’ 
follow-up for the SSM domains and subdomains. 
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